Phase 4 Safety and Efficacy Study of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients With Severe/Moderately Severe Hemophilia A

by Yongqiang Zhao PhD, Yu Hu PhD, Jie Jin PhD, Xielan Zhao PhD, Xuefeng Wang PhD, Runhui Wu PhD, Depei Wu MD, Renchi Yang PhD, Feng’e Yang MD, Qun Hu PhD, Juan Wang MD, Hai Fang MD, Werner Engl PhD
Published 2021-02-01